Focal Segmental Glomerulosclerosis
Open accessThe DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Abstract
Focal segmental glomerulosclerosis (FSGS) is a leading cause of kidney disease worldwide. The presumed etiology of primary FSGS is a plasma factor with responsiveness to immunosuppressive therapy and a risk of recurrence after kidney transplant–important disease characteristics. In contrast, adaptive FSGS is associated with excessive nephron workload due to increased body size, reduced nephron capacity, or single glomerular hyperfiltration associated with certain diseases. Additional etiologies are now recognized as drivers of FSGS: high-penetrance genetic FSGS due to mutations in one of nearly 40 genes, virus-associated FSGS, and medication-associated FSGS. Emerging data support the identification of a sixth category: APOL1 risk allele–associated FSGS in individuals with sub-Saharan ancestry. The classification of a particular patient with FSGS relies on integration of findings from clinical history, laboratory testing, kidney biopsy, and in some patients, genetic testing. The kidney biopsy can be helpful, with clues provided by features on light microscopy ( e.g ., glomerular size, histologic variant of FSGS, microcystic tubular changes, and tubular hypertrophy), immunofluorescence ( e.g ., to rule out other primary glomerulopathies), and electron microscopy ( e.g. , extent of podocyte foot process effacement, podocyte microvillous transformation, and tubuloreticular inclusions). A complete assessment of renal histology is important for establishing the parenchymal setting of segmental glomerulosclerosis, distinguishing FSGS associated with one of many other glomerular diseases from the clinical-pathologic syndrome of FSGS. Genetic testing is beneficial in particular clinical settings. Identifying the etiology of FSGS guides selection of therapy and provides prognostic insight. Much progress has been made in our understanding of FSGS, but important outstanding issues remain, including the identity of the plasma factor believed to be responsible for primary FSGS, the value of routine implementation of genetic testing, and the identification of more effective and less toxic therapeutic interventions for FSGS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Focal segmental glomerulosclerosis (FSGS) is a fibrotic kidney disease characterized by glomerular lesions, particularly in podocytes — the formation of adhesions in the glomerular capillary tuft leads to capillary occlusion and nephron degeneration162.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [162]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S., Prosek, J., Nadasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,376
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., McGuire, A. L., Nussbaum, R. L., O’Daniel, J. M., Ormond, K. E., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.73 · Cited by 2,541
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
Genovese, G., Friedman, D. J., Ross, M. D., Lecordier, L., Uzureau, P., Freedman, B. I., Bowden, D. W., Langefeld, C. D., Oleksyk, T. K., Uscinski Knob, A. L., et al. (2010) · Science · doi:10.1126/science.1193032 · Cited by 2,028 · cited 1×
“More recently, efforts to identify genetic drivers of FSGS in at-risk populations have gained momentum, with the most recent addition including the APOL1 genetic variant as a major association with FSGS in individuals of sub-Saharan African descent with FSGS (23).”
BackgroundSelf-citationMann, J. F., Schmieder, R. E., McQueen, M., Dyal, L., Schumacher, H., Pogue, J., Wang, X., Maggioni, A., Budaj, A., Chaithiraphan, S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61236-2 · Cited by 1,589
Combined angiotensin inhibition for the treatment of diabetic nephropathy
Fried, L. F., Emanuele, N., Zhang, J. H., Brophy, M., Conner, T. A., Duckworth, W., Leehey, D. J., McCullough, P. A., O'Connor, T., Palevsky, P. M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303154 · Cited by 1,169
(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.9 · Cited by 966
KDIGO Clinical Practice Guideline for Glomerulonephritis
Eckardt, K., & Kasiske, B. L. (2012) · Cited by 893
APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy
Kopp, J. B., Nelson, G. W., Sampath, K., Johnson, R. C., Genovese, G., An, P., Friedman, D., Briggs, W., Dart, R., Korbet, S., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011040388 · Cited by 855
Self-citationCirculating urokinase receptor as a cause of focal segmental glomerulosclerosis
Wei, C., El Hindi, S., Li, J., Fornoni, A., Goes, N., Sageshima, J., Maiguel, D., Karumanchi, S. A., Yap, H.-K., Saleem, M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2411 · Cited by 841
Cited by
Heavy metals: toxicity and human health effects
Jomova, K., Alomar, S. Y., Nepovimova, E., Kuca, K., & Valko, M. (2025) · Archives of Toxicology · doi:10.1007/s00204-024-03903-2 · Cited by 983
Kopp, J. B., Anders, H.-J., Susztak, K., Podestà, M. A., Remuzzi, G., Hildebrandt, F., & Romagnani, P. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0196-7 · Cited by 562
Self-citationAutophagy in kidney homeostasis and disease
Tang, C., Livingston, M. J., Liu, Z., & Dong, Z. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0309-2 · Cited by 496
Cellular and molecular mechanisms of kidney fibrosis
Djudjaj, S., & Boor, P. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.06.002 · Cited by 475
Chung, J.-J., Goldstein, L., Chen, Y.-J. J., Lee, J., Webster, J. D., Roose-Girma, M., Paudyal, S. C., Modrusan, Z., Dey, A., & Shaw, A. S. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020020220 · Cited by 188
Focal Segmental Glomerulosclerosis: State-of-the-Art and Clinical Perspective
Shabaka, A., Tato, A., & Juarez, G. M. F. (2020) · The Nephron journals/Nephron journals · doi:10.1159/000508099 · Cited by 186
Rovin, B. H., Caster, D. J., Cattran, D. C., Gibson, K. L., Hogan, J. J., Moeller, M. J., Roccatello, D., Cheung, M., Wheeler, D. C., Winkelmayer, W. C., et al. (2019) · Kidney International · doi:10.1016/j.kint.2018.11.008 · Cited by 185
Hu, S., Hang, X., Wei, Y., Wang, H., Zhang, L., & Zhao, L. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01502-3 · Cited by 166
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis
Rheault, M. N., Alpers, C. E., Barratt, J., Bieler, S., Canetta, P. A., Chae, D., Coppock, G., Diva, U., Gesualdo, L., Heerspink, H. J. L., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2308550 · Cited by 146
Wheeler, D. C., Jongs, N., Stefánsson, B. V., Chertow, G. M., Greene, T., Hou, F. F., Langkilde, A. M., McMurray, J. J. V., Rossing, P. R., Nowicki, M. P., et al. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab335 · Cited by 139
Insights into new-onset autoimmune diseases after COVID-19 vaccination
Guo, M., Liu, X., Chen, X., & Li, Q. (2023) · Autoimmunity Reviews · doi:10.1016/j.autrev.2023.103340 · Cited by 121
Politano, S. A., Colbert, G. B., & Hamiduzzaman, N. (2020) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2020.08.002 · Cited by 120
Antisense oligonucleotide treatment ameliorates IFN-γ–induced proteinuria in APOL1-transgenic mice
Aghajan, M., Booten, S. L., Althage, M., Hart, C. E., Ericsson, A., Maxvall, I., Ochaba, J., Menschik-Lundin, A., Hartleib, J., Kuntz, S., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126124 · Cited by 107
Mariani, L., Eddy, S. F., Alakwaa, F., McCown, P. J., Harder, J. L., Nair, V., Eichinger, F. H., Martini, S., Ademola, A. D., Boima, V., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.10.023 · Cited by 98
Self-citationProteinuric Kidney Diseases: A Podocyte's Slit Diaphragm and Cytoskeleton Approach
Yu, S. M.-W., Nissaisorakarn, P., Husain, I., & Jim, B. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00221 · Cited by 87
The Wnt Signaling Pathway in Diabetic Nephropathy
Wang, H., Zhang, R., Wu, X., Chen, Y., Ji, W., Wang, J., Zhang, Y., Xia, Y., Tang, Y., & Yuan, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.701547 · Cited by 87
Clinical Genetic Screening in Adult Patients with Kidney Disease
Cocchi, E., Nestor, J. G., & Gharavi, A. G. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.15141219 · Cited by 85
New Diabetes Therapies and Diabetic Kidney Disease Progression: the Role of SGLT-2 Inhibitors
Dekkers, C. C. J., Gansevoort, R. T., & Heerspink, H. J. L. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0992-6 · Cited by 81
Therapeutic plasma exchange: Review of current indications
Fernández-Zarzoso, M., Gómez‐Seguí, I., & de la Rubia, J. (2019) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2019.04.007 · Cited by 78
Lysophosphatidic Acid Signaling in Diabetic Nephropathy
Lee, J., Kim, D., Oh, Y. S., & Jun, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112850 · Cited by 78
Gauckler, P., Shin, J. I., Alberici, F., Audard, V., Bruchfeld, A. N., Busch, M., Cheung, C. K., Crnogorac, M., Delbarba, E., Eller, K., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102671 · Cited by 77
TRPC channels: Regulation, dysregulation and contributions to chronic kidney disease
Dryer, S. E., Roshanravan, H., & Kim, E. Y. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.04.001 · Cited by 73
Arif, E., Solanki, A. K., Srivastava, P., Rahman, B., Fitzgibbon, W. R., Deng, P., Budisavljevic, M. N., Baicu, C. F., Zile, M. R., Megyesi, J. K., et al. (2019) · Kidney International · doi:10.1016/j.kint.2019.03.023 · Cited by 71
Komers, R., Diva, U., Inrig, J. K., Loewen, A., Trachtman, H., & Rote, W. E. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2019.12.017 · Cited by 69
The Immune System and Idiopathic Nephrotic Syndrome
Campbell, R. E., & Thurman, J. M. (2022) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07180622 · Cited by 67
Jiang, H. N., Shen, Z., Zhuang, J., Chen, L., Qu, Y., Xu, C., Yang, S., & Tian, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1335936 · Cited by 68
Genetic Testing in Clinical Settings
Franceschini, N., Frick, A., & Kopp, J. B. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.02.351 · Cited by 65
Self-citationLabat‐de‐Hoz, L., & Alonso, M. A. (2021) · Cells · doi:10.3390/cells10102554 · Cited by 63
Glomerular Diseases in Children
Wenderfer, S. E., & Gaut, J. P. (2017) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2017.09.005 · Cited by 63
Contributions of Rare Gene Variants to Familial and Sporadic FSGS
Wang, M., Chun, J., Genovese, G., Knob, A. U., Benjamin, A., Wilkins, M. S., Friedman, D. J., Appel, G. B., Lifton, R. P., Mane, S., et al. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019020152 · Cited by 62
Zee, J., Liu, Q., Smith, A. R., Hodgin, J. B., Rosenberg, A. Z., Gillespie, B. W., Holzman, L. B., Barisoni, L. M. C., & Mariani, L. H. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021101396 · Cited by 59
Self-citationMiao, J., Vairo, F. P. E., Hogan, M. C., Erickson, S. B., Ters, M. E., Bentall, A., Kukla, A., Greene, E. L., Hernandez, L. H., Sethi, S. M., et al. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2021.01.037 · Cited by 59
Nephrotic Syndrome for the Internist
Ramirez, M. J. Z., Stein, E. J., & Jain, K. (2023) · Medical Clinics of North America · doi:10.1016/j.mcna.2023.03.006 · Cited by 55
Riedhammer, K. M., Braunisch, M. C., Günthner, R., Wagner, M., Hemmer, C., Strom, T. M., Schmaderer, C., Renders, L., Tasic, V. B., Gucev, Z. S., et al. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.12.008 · Cited by 55
Natural antibody and complement activation characterize patients with idiopathic nephrotic syndrome
Trachtman, H., Laskowski, J., Lee, C., Renner, B., Feemster, A., Parikh, S. M., Panzer, S. E., Zhong, W., Cravedi, P., Cantarelli, C., et al. (2021) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00041.2021 · Cited by 55
The formin INF2 in disease: progress from 10 years of research
Labat‐de‐Hoz, L., & Alonso, M. A. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03550-7 · Cited by 53
Martin, W. P., White, J. P., López-Hernández, F. J., Docherty, N. G., & le Roux, C. W. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00289 · Cited by 53
Autophagy in kidney disease: Advances and therapeutic potential
Bhatia, D., & Choi, M. E. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.01.008 · Cited by 52
Protective Role of the M-Sec–Tunneling Nanotube System in Podocytes
Barutta, F., Kimura, S., Hase, K., Bellini, S., Corbetta, B., Corbelli, A., Fiordaliso, F., Barreca, A., Papotti, M. G., Ghiggeri, G. M., et al. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020071076 · Cited by 51
Salfi, G., Casiraghi, F., & Remuzzi, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1247606 · Cited by 51
Merchant, M. L., Barati, M. T., Caster, D. J., Hata, J. L., Hobeika, L., Coventry, S. C., Brier, M. E., Wilkey, D. W., Li, M., Rood, I. M., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019070696 · Cited by 49
A Review of Focal Segmental Glomerulosclerosis Classification With a Focus on Genetic Associations
Bonilla, M. A., Efe, O., Selvaskandan, H., Lerma, E. V., & Wiegley, N. (2024) · Kidney Medicine · doi:10.1016/j.xkme.2024.100826 · Cited by 48
Caster, D. J., Magalhães, B., Pennese, N., Zaffalon, A., Faiella, M., Campbell, K. N., Radhakrishnan, J., Tesar, V., & Trachtman, H. (2022) · Kidney Medicine · doi:10.1016/j.xkme.2022.100501 · Cited by 47
Kienzl‐Wagner, K., Waldegger, S., & Schneeberger, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01669 · Cited by 47
Taiwan Society of Nephrology, Chiu, H., Chen, H., Lu, K., & Shu, K. (2018) · BMC Nephrology · doi:10.1186/s12882-017-0810-4 · Cited by 47
Ballestas, E. R., & Reid‐Adam, J. (2022) · Pediatrics in Review · doi:10.1542/pir.2020-001230 · Cited by 46
Focal Segmental Glomerulosclerosis
Suresh, V., Stillman, I. E., Campbell, K. N., & Meliambro, K. A. (2024) · Advances in Kidney Disease and Health · doi:10.1053/j.akdh.2024.03.009 · Cited by 44
Pathogenesis of Focal Segmental Glomerulosclerosis and Related Disorders
Altintas, M. M., Agarwal, S., Sudhini, Y. R., Zhu, K., Wei, C., & Reiser, J. (2025) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-051220-092001 · Cited by 44
Urinary Protein and Peptide Markers in Chronic Kidney Disease
Chebotareva, N. V., Vinogradov, A. A., McDonnell, V., Zakharova, N. V., Indeykina, M. I., Moiseev, S. V., Николаев, Е. Н., & Kononikhin, A. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212123 · Cited by 43
Qiao, J., Liu, Y., Jiang, Z., Yang, Y. G., Liu, W., & Han, B. (2018) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.06.109 · Cited by 42
Fibrosis, the Bad Actor in Cardiorenal Syndromes: Mechanisms Involved
Delgado‐Valero, B., Cachofeiro, V., & Martínez‐Martínez, E. (2021) · Cells · doi:10.3390/cells10071824 · Cited by 41
MiRNAs as potential biomarker of kidney diseases: A review
Ramanathan, K., & Padmanabhan, G. (2020) · Cell Biochemistry and Function · doi:10.1002/cbf.3555 · Cited by 41
Kohan, D. E., Bedard, P. W., Jenkinson, C. P., Hendry, B. M., & Komers, R. (2024) · Clinical Science · doi:10.1042/cs20240249 · Cited by 40
The Renal Pathology of Obesity: Structure-Function Correlations
Tsuboi, N., & Okabayashi, Y. (2021) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2021.06.002 · Cited by 40
Tousson-Abouelazm, N., Papillon, J., Guillemette, J., & Cybulsky, A. V. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-0416-5 · Cited by 38
Post-Translational Modification and Natural Mutation of TRPC Channels
Liu, X., Yao, X., & Tsang, S. Y. (2020) · Cells · doi:10.3390/cells9010135 · Cited by 38
The role of mitochondrial dysfunction in kidney injury and disease
Jia, X., Zhu, L., Zhu, Q., & Zhang, J. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103576 · Cited by 37
Usui, T., Morito, N., Shawki, H. H., Sato, Y., Tsukaguchi, H., Hamada, M., Jeon, H., Yadav, M. K., Kuno, A., Tsunakawa, Y., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.02.038 · Cited by 37
Idiopathic nephrotic syndrome and serum permeability factors: a molecular jigsaw puzzle
Candelier, J., & Lorenzo, H. K. (2019) · Cell and Tissue Research · doi:10.1007/s00441-019-03147-y · Cited by 37
Bellur, S. S., Troyanov, S., Vorobyeva, O. A., Coppo, R., Roberts, I. S. D., Coppo, R., Feehaly, J., Troyanov, S., Cattran, D. C., Cook, H. T., et al. (2024) · Kidney International · doi:10.1016/j.kint.2024.03.011 · Cited by 36
Programming of Renal Development and Chronic Disease in Adult Life
Lumbers, E. R., Kandasamy, Y., Delforce, S. J., Boyce, A. C., Gibson, K. J., & Pringle, K. G. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00757 · Cited by 36
The Role of Wnt Signalling in Chronic Kidney Disease (CKD)
Malik, S. A., Modarage, K., & Goggolidou, P. (2020) · Genes · doi:10.3390/genes11050496 · Cited by 35
Müller‐Deile, J., Sarau, G., Kotb, A. M., Jaremenko, C., Rolle-Kampczyk, U. E., Daniel, C., Kalkhof, S., Christiansen, S. H., & Schiffer, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-83883-w · Cited by 35
Kim, E. Y., Khayyat, N. H., & Dryer, S. E. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.08.007 · Cited by 35
Puig-Gay, N., Jacobs-Cachá, C., Sellarès, J., Guirado, L., Roncero, F. G., Jiménez, C., Zárraga, S., Paúl, J., Lauzurica, R., Alonso, Á., et al. (2018) · Transplant International · doi:10.1111/tri.13372 · Cited by 35
Targeted nanotherapy for kidney diseases: a comprehensive review
Sabiu, G., Kasinath, V., Jung, S., Li, X., Tsokos, G. C., & Abdi, R. (2022) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfac233 · Cited by 33
An Updated Comprehensive Review on Diseases Associated with Nephrotic Syndromes
Wendt, R. T., Sobhani, A., Diefenhardt, P., Trappe, M., & Völker, L. A. (2024) · Biomedicines · doi:10.3390/biomedicines12102259 · Cited by 33
Jacobs-Cachá, C., Vergara, A., García-Carro, C., Agraz, I., Toapanta, N., Ariceta, G., Moreso, F., Serón, D., López-Hellín, J., & Soler, M. J. (2020) · Clinical Kidney Journal · doi:10.1093/ckj/sfaa110 · Cited by 33
The role of oxidized phospholipids in the development of disease
Nie, J. S., Yang, J., Wei, Y., & Wei, X. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100909 · Cited by 33
PD-1 immunobiology in glomerulonephritis and renal cell carcinoma
Curran, C. S., & Kopp, J. B. (2021) · BMC Nephrology · doi:10.1186/s12882-021-02257-6 · Cited by 33
Self-citationBagang, N., Gupta, K., Singh, G., Kanuri, S. H., & Mehan, S. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110470 · Cited by 33
Refaeli, I., Hughes, M. R., Wong, A. K.-W., Bissonnette, M. L. Z., Roskelley, C. D., Vogl, A. W., Barbour, S. J., Freedman, B., & McNagny, K. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-64907-3 · Cited by 33
da Silva, C. A., Monteiro, M. L. G. D. R., Araújo, L. S., Urzedo, M. G., Rocha, L. B., dos Reis, M. A., & Machado, J. R. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241745 · Cited by 33
Proteome Analysis of Isolated Podocytes Reveals Stress Responses in Glomerular Sclerosis
Koehler, S., Kuczkowski, A., Kühne, L., Jüngst, C., Hoehne, M., Grahammer, F., Eddy, S. F., Kretzler, M., Beck, B. B., Höhfeld, J., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019030312 · Cited by 31
MicroRNAs as Biomarkers for Nephrotic Syndrome
Tsuji, K., Kitamura, S., & Wada, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010088 · Cited by 31
Sambharia, M., Rastogi, P., & Thomas, C. P. (2022) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31990 · Cited by 31
N6-methyladenine RNA Methylation Epigenetic Modification and Kidney Diseases
Luan, J., Kopp, J. B., & Zhou, H. (2022) · Kidney International Reports · doi:10.1016/j.ekir.2022.10.009 · Cited by 31
Self-citationChun, J., Wang, M., Wilkins, M. S., Knob, A. U., Benjamin, A., Bu, L., & Pollak, M. R. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2019.12.016 · Cited by 31
TRPC6 Inhibitor BI 764198 in Focal Segmental Glomerulosclerosis: Phase 2 Study Design
Trachtman, H., Kretzler, M., Desmond, H. E., Choi, W., Manuel, R. C., & Soleymanlou, N. (2023) · Kidney International Reports · doi:10.1016/j.ekir.2023.09.026 · Cited by 30
Role of Podocyte in Kidney Disease
Husain, S. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2907250 · Cited by 30
Otalora, L., Chavez, E., Watford, D. J., Tueros, L., Correa, M. M., Nair, V., Ruiz, P., WAHL, P. W., Eddy, S. F., Martini, S., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222948 · Cited by 30
Emerging drugs for treatment of focal segmental glomerulosclerosis
Trachtman, H. (2020) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2020.1803276 · Cited by 30
Fishman, C. E., Mohebnasab, M., van Setten, J., Zanoni, F., Wang, C., Deaglio, S., Amoroso, A., Callans, L. E., van Gelder, T., Lee, S. H., et al. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01084 · Cited by 30
The Role of Rituximab in Primary Focal Segmental Glomerular Sclerosis of the Adult
Tedesco, M., Mescia, F., Pisani, I., Allinovi, M., Casazza, G., Vecchio, L. D., Santostefano, M., Cirillo, L., Ferrario, F., Esposito, C., et al. (2022) · Kidney International Reports · doi:10.1016/j.ekir.2022.05.024 · Cited by 29
Ye, Q., Lan, B., Liu, H., Persson, P. B., Lai, E. Y., & Mao, J. (2022) · Acta Physiologica · doi:10.1111/apha.13850 · Cited by 29
A pilot study of anti‐nephrin antibodies in podocytopaties among adults
Chebotareva, N. V., Vinogradov, A. A., Birukova, Y., Игоревич, А. И., Sergeeva, N. S., Chemodanova, D., Kononikhin, A. S., & Moiseev, S. V. (2023) · Nephrology · doi:10.1111/nep.14249 · Cited by 29
Randomized Clinical Trial Design to Assess Abatacept in Resistant Nephrotic Syndrome
Trachtman, H., Gipson, D. S., Somers, M. J. G., Spino, C., Adler, S. G., Holzman, L. B., Kopp, J. B., Sedor, J. R., Overfield, S., Elegbe, A., et al. (2017) · Kidney International Reports · doi:10.1016/j.ekir.2017.08.013 · Cited by 29
Self-citationMolecular profiling of urinary extracellular vesicles in chronic kidney disease and renal fibrosis
Tepus, M., Tonoli, E., & Verderio, E. A. M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1041327 · Cited by 26
FSGS-Causing INF2 Mutation Impairs Cleaved INF2 N-Fragment Functions in Podocytes
Subramanian, B., Chun, J., Perez-Gill, C., Yan, P., Stillman, I. E., Higgs, H. N., Alper, S. L., Schlöndorff, J. S., & Pollak, M. R. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019050443 · Cited by 28
Urinary Extracellular Vesicles in Chronic Kidney Disease: From Bench to Bedside?
Delrue, C., Bruyne, S. D., Speeckaert, R., & Speeckaert, M. M. (2023) · Diagnostics · doi:10.3390/diagnostics13030443 · Cited by 27
Tsuchimoto, A., Matsukuma, Y., Ueki, K., Tanaka, S., Masutani, K., Nakagawa, K., Mitsuiki, K., Uesugi, N., Katafuchi, R., Tsuruya, K., et al. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy374 · Cited by 27
Urinary CD80 Discriminates Among Glomerular Disease Types and Reflects Disease Activity
Guerrico, A. M. G., Lieske, J. C., Klee, G. G., Kumar, S., López‐Báez, V., Wright, A. M., Bobart, S. A., Shevell, D. E., Maldonado, M. A., Troost, J. P., et al. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2020.08.001 · Cited by 27
Dou, Y., Yichun, S., Shen, Y., Qu, J., Liu, C., & Cao, J. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118010 · Cited by 26
Combination of Transfer Learning Methods for Kidney Glomeruli Image Classification
Lee, H.-C., & Aqil, A. F. (2022) · Applied Sciences · doi:10.3390/app12031040 · Cited by 26
The New Challenge of Obesity - Obesity-Associated Nephropathy
Hao, M., Lv, Y., Liu, S. J., & Guo, W. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s433649 · Cited by 26
Raina, R., Krishnappa, V., Sanchez-Kazi, C., Quiroga, A., Twombley, K. E., Mathias, R., Lo, M. M., Chakraborty, R., Mahesh, S., Steinke, J. M., et al. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00454 · Cited by 26
New Insights into the Treatment of Glomerular Diseases: When Mechanisms Become Vivid
Lin, D.-W., Chang, C., Hsu, Y., & Lin, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073525 · Cited by 26
Autoimmunity in Focal Segmental Glomerulosclerosis: A Long-Standing Yet Elusive Association
Podestà, M. A., & Ponticelli, C. E. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.604961 · Cited by 25
Sharma, M., Singh, V., Sharma, R., Koul, A., McCarthy, E. T., Savin, V. J., Joshi, T., & Srivastava, T. (2022) · Biomedicines · doi:10.3390/biomedicines10020407 · Cited by 25
The Pathology Lesion Patterns of Podocytopathies: How and why?
Ravaglia, F., Melica, M. E., Angelotti, M. L., Chiara, L. D., Romagnani, P., & Lasagni, L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.838272 · Cited by 25
Metadata
- Authors
- Rosenberg, A. Z., & Kopp, J. B.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Rosenberg, Avi Z.
- Kopp, Jeffrey B.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2017-02-27
- Volume
- 12
- Issue
- 3
- Pages
- 502-517
- ISSN
- 1555-9041 (ISSN-L)
- 1555-905X
- PMC
- PMC5338705
- OpenAlex
- W2593771998
- Cited by
- 562
- References
- 145
- Citations by year
- 2026: 43 · 2025: 71 · 2024: 86 · 2023: 79 · 2022: 79 · 2021: 62 · 2020: 65 · 2019: 46 · 2018: 22 · 2017: 9
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Johns Hopkins University
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Keywords
- focal segmental glomerulosclerosis, APOL1 risk alleles, renal biopsy, podocyte ultrastructure, genetic testing
- MeSH terms
- Apolipoprotein L1, Angiotensin-Converting Enzyme Inhibitors, Drug Therapy, Combination, Glomerulosclerosis, Focal Segmental, Glucocorticoids, Humans, Immunosuppressive Agents, HIV Infections, Angiotensin Receptor Antagonists, Calcineurin Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.